--- title: "CervoMed (CRVO.US) — 財務報表" type: "Symbol" locale: "zh-HK" url: "https://longbridge.com/zh-HK/quote/CRVO.US/norm.md" symbol: "CRVO.US" name: "CervoMed" parent: "https://longbridge.com/zh-HK/quote/CRVO.US.md" datetime: "2026-03-17T16:24:07.559Z" locales: - [en](https://longbridge.com/en/quote/CRVO.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/CRVO.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/CRVO.US/norm.md) --- > 支持的語言: [English](https://longbridge.com/en/quote/CRVO.US/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/CRVO.US/norm.md) # CervoMed (CRVO.US) — 財務報表 ## 損益表 (USD) | 指標 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | EPS | -0.8738 | -0.8351 | -0.6992 | -0.5624 | -0.7701 | | ROE | -146.26% | -103.97% | -73.55% | -53.03% | -63.23% | | Revenue | 8726.00 | 322569.00 | 1.76M | 1.92M | 2.16M | | Net income | -8.09M | -7.73M | -6.26M | -4.89M | -6.71M | | Operating income | -8.33M | -8.04M | -6.62M | -5.30M | -7.24M | | Gross margin | -66714.20% | -1772.60% | -190.64% | -152.30% | -227.78% | | Net margin | -92680.38% | -2395.34% | -356.05% | -255.23% | -310.17% | | Profit quality | - | - | - | - | - | ## 資產負債表 (USD) | 指標 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | A&L | 22.88M | 30.61M | 38.08M | 38.58M | 43.08M | | Leverage | 1.26 | 1.18 | 1.14 | 1.11 | 1.10 | | BVPS | 1.97 | 2.81 | 3.61 | 3.98 | 4.50 | | Turnover | 0.1215 | 0.1550 | 0.1704 | 0.3997 | 0.3671 | | Cash & STI | 20.86M | 27.29M | 33.53M | 35.24M | 38.92M | | Inv & Rec | - | - | - | - | - | | LT assets | - | - | - | - | - | | Net debt | -20.86M | -27.29M | -33.53M | -35.24M | -38.92M | ## 現金流量表 (USD) | 指標 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | Operating CF | -6.58M | -6.47M | -6.51M | -3.89M | -8.05M | | Investing CF | 5.37M | 7.58M | -254993.00 | 5.40M | 9.31M | | Financing CF | 0.0000 | 0.0000 | 4.59M | - | 0.0000 | | Free CF | -3.55M | -3.54M | -4.16M | -2.06M | -5.56M | | OCF coverage | - | - | - | - | - | | Repaid & issued | - | - | - | - | - | | CapEx | - | - | - | - | - |